---
layout: post
title: "Guidance Documents Related to Coronavirus Disease 2019; Availability"
date: 2026-02-05 18:58:55 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-08564
original_published: 2022-04-22 00:00:00 +0000
significance: 8.00
---

# Guidance Documents Related to Coronavirus Disease 2019; Availability

**Published:** February 05, 2026 18:58 UTC
**Source:** Federal Register
**Original Published:** April 22, 2022 00:00 UTC
**Document Number:** 2022-08564

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of an FDA guidance document related to the Coronavirus Disease 2019 (COVID-19) public health emergency (PHE). This notice of availability (NOA) is pursuant to the process that FDA announced, in the Federal Register of March 25, 2020, for making available to the public COVID-19-related guidances. The guidance identified in this notice addresses issues related to the COVID-19 PHE and has been issued in accordance with the process announced in the March 25, 2020, notice. The guidance has been implemented without prior comment, but it remains subject to comment in accordance with the Agency's good guidance practices.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/04/22/2022-08564/guidance-documents-related-to-coronavirus-disease-2019-availability)
- API: https://www.federalregister.gov/api/v1/documents/2022-08564

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
